Intrinsic Value of S&P & Nasdaq Contact Us

NuVasive, Inc. NUVA NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
48/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$58.00
+45.9%

NuVasive, Inc. (NUVA) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in San Diego, CA, United States. The current CEO is J. Christopher Barry.

NUVA has IPO date of 2004-05-13, 3,000 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $2.08B.

About NuVasive, Inc.

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.

📍 7475 Lusk Boulevard, San Diego, CA 92121 📞 858 909 1800
Company Details
SectorHealthcare
IndustryMedical - Devices
CountryUnited States
ExchangeNASDAQ Global Select
CurrencyUSD
IPO Date2004-05-13
CEOJ. Christopher Barry
Employees3,000
Trading Info
Current Price$39.75
Market Cap$2.08B
52-Week Range35.17-49.53
Beta1.07
ETFNo
ADRNo
CUSIP670704105
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message